Fisher Asset Management
LXEO icon

Fisher Asset Management’s Lexeo Therapeutics LXEO Stock Holding History

Fisher Asset Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$532K Buy
+114,322
New +$618K ﹤0.01% 797

Other funds holding LXEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Fisher Asset Management's LXEO Position: Q2 2026 in Review

Fisher Asset Management opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 114,322 shares worth $532K. The stake represents ﹤0.01% of the portfolio and ranks #797 among its holdings.

37 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Fisher Asset Management held 114,322 shares of Lexeo Therapeutics worth $532K as of Q2 2026.
  • Lexeo Therapeutics was a new Fisher Asset Management position in Q2 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #797 holding.
  • 37 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.